KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Liabilities and Shareholders Equity: 2009-2024

Historic Liabilities and Shareholders Equity for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $3.3 billion.

  • Idexx Laboratories' Liabilities and Shareholders Equity rose 1.07% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 billion, marking a year-over-year decrease of 1.15%. This contributed to the annual value of $3.3 billion for FY2024, which is 1.03% up from last year.
  • According to the latest figures from FY2024, Idexx Laboratories' Liabilities and Shareholders Equity is $3.3 billion, which was up 1.03% from $3.3 billion recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Liabilities and Shareholders Equity ranged from a high of $3.3 billion in FY2024 and a low of $2.3 billion during FY2020.
  • In the last 3 years, Idexx Laboratories' Liabilities and Shareholders Equity had a median value of $3.3 billion in 2023 and averaged $3.1 billion.
  • Data for Idexx Laboratories' Liabilities and Shareholders Equity shows a peak YoY increased of 25.22% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Idexx Laboratories' Liabilities and Shareholders Equity stood at $2.3 billion in 2020, then increased by 6.22% to $2.4 billion in 2021, then rose by 12.70% to $2.7 billion in 2022, then rose by 18.68% to $3.3 billion in 2023, then grew by 1.03% to $3.3 billion in 2024.